ATE463262T1 - Herstellungsverfahren zur kontrolle der teilchengrösse von albumin macroaggregaten - Google Patents
Herstellungsverfahren zur kontrolle der teilchengrösse von albumin macroaggregatenInfo
- Publication number
- ATE463262T1 ATE463262T1 AT02719093T AT02719093T ATE463262T1 AT E463262 T1 ATE463262 T1 AT E463262T1 AT 02719093 T AT02719093 T AT 02719093T AT 02719093 T AT02719093 T AT 02719093T AT E463262 T1 ATE463262 T1 AT E463262T1
- Authority
- AT
- Austria
- Prior art keywords
- serum albumin
- macroaggregates
- reaction mixture
- controlling
- particle size
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 239000002245 particle Substances 0.000 title abstract 3
- 108010013207 macro aggregates of albumin Proteins 0.000 title 1
- 102000007562 Serum Albumin Human genes 0.000 abstract 4
- 108010071390 Serum Albumin Proteins 0.000 abstract 4
- 239000011541 reaction mixture Substances 0.000 abstract 3
- 102000008100 Human Serum Albumin Human genes 0.000 abstract 1
- 108091006905 Human Serum Albumin Proteins 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 230000003139 buffering effect Effects 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 150000004820 halides Chemical class 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 229940102213 injectable suspension Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000008227 sterile water for injection Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1255—Granulates, agglomerates, microspheres
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/795,272 US6730286B2 (en) | 2001-02-28 | 2001-02-28 | Manufacturing process to control particle size |
| PCT/US2002/006023 WO2002067997A1 (en) | 2001-02-28 | 2002-02-27 | Manufacturing process to control particle size |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE463262T1 true ATE463262T1 (de) | 2010-04-15 |
Family
ID=25165150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02719093T ATE463262T1 (de) | 2001-02-28 | 2002-02-27 | Herstellungsverfahren zur kontrolle der teilchengrösse von albumin macroaggregaten |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6730286B2 (de) |
| EP (1) | EP1370300B1 (de) |
| JP (1) | JP2004521920A (de) |
| AT (1) | ATE463262T1 (de) |
| CA (1) | CA2438902C (de) |
| DE (1) | DE60235875D1 (de) |
| WO (1) | WO2002067997A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006066595A2 (en) * | 2004-12-22 | 2006-06-29 | Novozymes A/S | Recombinant production of serum albumin |
| US20070259348A1 (en) * | 2005-05-03 | 2007-11-08 | Handylab, Inc. | Lyophilized pellets |
| EP2471557A1 (de) | 2010-12-27 | 2012-07-04 | Università degli Studi di Genova | Konjugat von Humanalbumin und 2-(4-Isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecan-1,4,7,10-tetraessigsäure zur Lokalisierung von Radionukliden zu diagnostischen und therapeutischen Zwecken |
| BE1027699B1 (fr) * | 2021-01-28 | 2022-04-01 | Trasis S A | Procédé de purification de macro-agrégats de sérumalbumine humaine radiomarqués |
| WO2025099636A1 (en) * | 2023-11-08 | 2025-05-15 | Jubilant Draximage Inc | Albumin conjugates and radiopharmaceutical compositions thereof |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3674900A (en) | 1967-01-03 | 1972-07-04 | Lloyd M Thompson | Radioactive macroaggregates of serum albumin |
| US3758678A (en) * | 1968-09-26 | 1973-09-11 | Minnesota Mining & Mfg | Biodegradable radioactive polysaccharide particles |
| FR2088139B1 (de) * | 1970-05-22 | 1973-06-08 | Philips France | |
| US3862299A (en) | 1970-09-23 | 1975-01-21 | Squibb & Sons Inc | Technetium-99m albumin aggregates |
| BE786566A (fr) | 1971-07-20 | 1973-01-22 | Squibb & Sons Inc | Agregats a base de tc-99m et d'albumine |
| US3863004A (en) | 1972-03-20 | 1975-01-28 | Mallinckrodt Chemical Works | Denatured macroprotein with divalent tin for tagging with technetium-99m and method of preparation |
| US3875299A (en) * | 1972-05-05 | 1975-04-01 | Medi Physics Inc | Technetium labeled tin colloid radiopharmaceuticals |
| US4024233A (en) | 1972-06-05 | 1977-05-17 | Medi-Physics, Inc. | 99M-technetium labeled macroaggregated human serum albumin pharmaceutical |
| US3987157A (en) | 1974-08-29 | 1976-10-19 | Union Carbide Corporation | Technetium 99-m labeled radio-diagnostic agents employing stannous tartrate and method of preparation |
| US4042677A (en) * | 1974-08-29 | 1977-08-16 | Union Carbide Corporation | Technetium-99m labeled radiodiagnostic agents and method of preparation |
| FR2288477A1 (fr) | 1974-10-22 | 1976-05-21 | Manche Union Coop Agr Laiti | Procede de production d'acide sialique et de glycoproteines a partir de lactoserum de fromagerie |
| US4094965A (en) | 1977-04-01 | 1978-06-13 | New England Nuclear Corporation | Diagnostic agents containing albumin and method for making same |
| US4187285A (en) | 1977-12-16 | 1980-02-05 | E. R. Squibb & Sons, Inc. | Microaggregated albumin |
| CA1112162A (en) * | 1978-04-20 | 1981-11-10 | Eugene L. Saklad | Albumin microaggregates for radioactive scanning of reticuloendothelial systems |
| JPS5659716A (en) | 1979-10-22 | 1981-05-23 | Toyo Soda Mfg Co Ltd | Separating method of gamma-globulin aggregate with membrane |
| CH652599A5 (de) * | 1981-08-28 | 1985-11-29 | Solco Basel Ag | Verfahren zur herstellung physiologisch abbaubarer kolloidaler, human-serumalbumin enthaltender produkte und ihre verwendung. |
| US5096696A (en) * | 1990-02-05 | 1992-03-17 | The Research Foundation Of State University Of New York | Binding of radiolabeled albumin fragments to fibrin clots |
| US5232828A (en) * | 1992-03-09 | 1993-08-03 | Becton, Dickinson And Company | Coating agents for cell recovery |
| US5521287A (en) | 1992-05-20 | 1996-05-28 | The Green Cross Corporation | Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same |
| JPH07126182A (ja) * | 1993-10-27 | 1995-05-16 | Green Cross Corp:The | 組換えヒト血清アルブミン製剤の滅菌方法 |
| US5589189A (en) * | 1994-09-14 | 1996-12-31 | Nexstar Pharmaceuticals, Inc. | Liposome dispersion |
-
2001
- 2001-02-28 US US09/795,272 patent/US6730286B2/en not_active Expired - Fee Related
-
2002
- 2002-02-27 AT AT02719093T patent/ATE463262T1/de not_active IP Right Cessation
- 2002-02-27 EP EP02719093A patent/EP1370300B1/de not_active Expired - Lifetime
- 2002-02-27 JP JP2002567361A patent/JP2004521920A/ja active Pending
- 2002-02-27 WO PCT/US2002/006023 patent/WO2002067997A1/en not_active Ceased
- 2002-02-27 DE DE60235875T patent/DE60235875D1/de not_active Expired - Lifetime
- 2002-02-27 CA CA002438902A patent/CA2438902C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1370300A1 (de) | 2003-12-17 |
| EP1370300A4 (de) | 2008-03-05 |
| US20020182148A1 (en) | 2002-12-05 |
| EP1370300B1 (de) | 2010-04-07 |
| DE60235875D1 (de) | 2010-05-20 |
| CA2438902C (en) | 2010-01-05 |
| US6730286B2 (en) | 2004-05-04 |
| WO2002067997A1 (en) | 2002-09-06 |
| JP2004521920A (ja) | 2004-07-22 |
| CA2438902A1 (en) | 2002-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2285785T3 (es) | Estimulacion de celulas hematopoyeticas in vitro. | |
| ES2724451T3 (es) | ICOS regula fundamentalmente la expansión y la función de linfocitos Th17 humanos inflamatorios | |
| ATE456378T1 (de) | Behandlung und verhütung von neoplasmatischen und infektiösen erkrankungen mit hitzeschock / stress proteinen | |
| Johansson et al. | In vitro biosynthesis of cold insoluble globulin (fibronectin) by mouse peritoneal macrophages | |
| JP2003530070A5 (de) | ||
| CN100510060C (zh) | 抗原特异性细胞毒性t细胞的扩大培养方法 | |
| ZA975851B (en) | Hepatocyte grown factor receptor agonists and uses thereof | |
| DE69535018D1 (de) | Papillomavirus vakzine | |
| BR9814487A (pt) | "vacina" | |
| WO1996011272A3 (de) | Papillomavirusähnliche partikel, fusionsproteine sowie verfahren zu deren herstellung | |
| DE69739268D1 (de) | Herstellung und reinigung von hepatitis c virus-ähnlichen partikeln | |
| DE69930630D1 (de) | B2microglobulin fusionsproteine und varianten mit hoher affinität | |
| DE69929612D1 (de) | Purifikation von viruspräparaten | |
| BR0314373A (pt) | Produto imunogênico estável para a indução de anticorpos contra uma ou várias proteìnas antigênicas em um indivìduo, composições farmacêutica, imunogênica e de vacina e processo de preparação de um produto imunogênico | |
| ES2246566T5 (es) | Aplicacion de proteinas hsp70. | |
| AU2003229834B2 (en) | Methods for producing gamma delta T cells | |
| ATE463262T1 (de) | Herstellungsverfahren zur kontrolle der teilchengrösse von albumin macroaggregaten | |
| CN117004564A (zh) | 调节性t细胞培养组合物及其用途 | |
| CA2125181A1 (en) | Trophoblast interferons and their use | |
| Dumont et al. | Control of the antitumoral activity of human macrophages produced in large amounts in view of adoptive transfer | |
| ATE169958T1 (de) | Herstellung der p1 proteine und impfstoffe gegen gonorrhöe | |
| Totsuka et al. | Enhancement of antigen-specific IFN-γ production from CD8+ T cells by a single amino acid-substituted peptide derived from bovine αs1-casein | |
| Islami et al. | Ex vivo expansion of umbilical cord blood hematopoietic stem cells on collagen-fibronectin coated electrospun nano scaffold | |
| WO1991018925A1 (en) | Novel megakaryocyte colony stimulating factor and production thereof | |
| Glade et al. | Human lymphoid cell lines: Models for immunological analysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |